
Opinion|Videos|November 7, 2023
Rectal Separation for Prostate Cancer Radiation Therapy: Clinical Data on SpaceOAR and SpaceOAR Vue
The SpaceOAR rectal spacer phase 3 trial showed reduced toxicity and improved quality of life, leading to FDA approval, but device-related side effects have emerged with broader clinical use.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
MRI, myths, and precision: Stacy Loeb, MD, discusses modern prostate cancer screening
2
Theranostic therapies expand frontline use in prostate cancer
3
Health Canada approves testosterone undecanoate for hypogonadism
4
Aaron Hansen, MD, shares key findings from the theraPb trial in mCRPC
5





















